FEATURED APPLICATION CONTENT

• Mammalian Expression

  See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

• Integrated Stability Workflows That Reduce Manual Data Handling

  Integrated accelerated stability workflows reduce manual data handling while improving confidence in shelf‑life predictions. Help your teams move faster with fewer experimental demands.

• Workflow For Chemical Characterization And Database Curation

  Confident identification of known and unknown compounds starts with smarter LC/MS and GC/MS workflows. Learn how structure elucidation, verification, and centralized data curation work together.

• Improving pKa Prediction Accuracy For PROTACs

  Gain insight into how localized modeling of ionizable centers, supported by curated experimental data, delivers reliable predictions that strengthen physicochemical decision-making.

• Property-Based Optimization Of Pharmaceutical Lead Compounds

  Property-driven optimization helps medicinal chemists focus synthetic effort where it matters most. See how integrating ADME and physicochemical predictions can surface better-balanced lead candidates.

• Deepening Digitalization In Drug Discovery At PTC Therapeutics

  Digital integration of physicochemical property prediction transforms how chemists evaluate compounds, enabling faster analysis, stronger structure, and more informed decisions across libraries.

• Accelerating Structure Verification Across Novartis

  Automated structure verification integrated into open-access NMR workflows cuts review time dramatically while maintaining confidence in results. See how smart parameter optimization improves efficiency.

• How GSK Are Revolutionizing HTE

  High-throughput chemistry delivers speed and efficiency, but only with the right digital backbone. See how integrated automation and analytics help chemists extract more value from every plate.

• The Future Of DMTA In Drug Discovery And Development

  AI‑enabled DMTA cycles connect design, experimentation, and analysis through structured data and automation, reducing manual handoffs while accelerating discovery, development, and CMC decision‑making.

• Multi-Technique, Vendor Neutral Analytical Data Handling For Chemists

  Managing analytical data across instruments doesn’t have to slow decision-making. Learn how a vendor-neutral, multi-technique approach helps chemists access, process, and report results efficiently.

• Simplify And Streamline Method Development With In Silico Modeling

  Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

• Standardization Of Analytical Data: Best Practices

  Standardized analytical data is key to improving data quality, reuse, and AI readiness. Explore the challenges of fragmented formats and gain practical guidance on building future-proof foundations.